Wisnu Barlianto
Prof. Dr. dr. Wisnu Barlianto, M.Si.Med, Sp.A(K) (born 26 July 1973) is an Indonesian physician, pediatric allergist-immunologist consultant, and medical education executive. He serves as a full Professor of Child Health and the Dean of the Faculty of Medicine at Brawijaya University (FKUB) in Malang, East Java, currently serving his second consecutive term. Beyond his university governance roles, he serves as the national General Chair of the Association of Indonesian Medical Education Institutions (AIPKI).
Education
Wisnu Barlianto was born in Bandung, West Java. He pursued his undergraduate medical studies at the Faculty of Medicine at Brawijaya University, graduating with his medical doctor (dr.) degree in 1997. He then completed postgraduate medical training in pediatric medicine alongside a Master of Biomedical Sciences (M.Si.Med) degree at Diponegoro University in Semarang in 2005. His master's research evaluated clinical triggers and correlations regarding environmental smoke exposures in light-to-moderate childhood asthma cohorts.
In 2011, Barlianto received his Doctorate in Medical Science (Dr.) from Brawijaya University. In the same year, he earned professional subspecialist accreditation as a Pediatric Allergy and Immunology Consultant from the Indonesian College of Pediatrics.
Academic and leadership career
Barlianto joined the faculty of Brawijaya University as a lecturer in child health in 2005. He entered administrative university governance in 2012 upon his appointment as the secretary of the medical department. In 2015, he was promoted to Vice Dean for Academic Affairs within the Faculty of Medicine.
In 2019, he was elected to his first term as the Dean of the Faculty of Medicine. Following institutional restructuring, he was re-appointed and sworn in by the university rector for a second consecutive five-year term in February 2023.
On 19 December 2024, Barlianto was formally inaugurated as a full Professor (Guru Besar) in Child Health at Brawijaya University. His inaugural professor oratorical paper introduced the "Asma Cermat" framework, a preventative management model for pediatric asthma that integrates targeted immunomodulation therapies with family-centered environmental modifications and specific nutritional interventions.
In June 2025, Barlianto entered national academic governance when he was elected General Chair (Ketua Umum) of the Association of Indonesian Medical Education Institutions (AIPKI) for the 2025–2028 term. In this role, he oversees the standardization of curriculums across Indonesia's medical education programs. During international institutional visits, he has worked to enhance clinical research partnerships between Indonesian and international health sciences networks. Locally, he has advocated for public health caution among regional healthcare workers regarding preventative immunization policies.
Research and clinical work
Barlianto's primary scientific inquiries focus on childhood immunodeficiencies, juvenile systemic lupus erythematosus (SLE), and drug hypersensitivities in early childhood development. His clinical research includes assessing the relationship between serum vitamin D levels and regulatory T-cell responses in pediatric lupus cohorts, as well as randomized trials exploring plant-derived immunomodulators for infantile chronic asthma.
In addition to his academic research, he maintains clinical operations as a senior consultant pediatrician in Malang, practicing at the Brawijaya University Hospital (RSUB), RSI Aisyiyah Malang, and the RSUD Dr. Saiful Anwar regional general hospital.